Jane Street Group, LLC Erytech Pharma S.A. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$1.03 - $1.8 $50,133 - $87,611	-48,673 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.36 - $2.35 $4,126 - $7,129	3,034 Added 6.65%	48,673 $93,000
Q4 2021 Feb 15, 2022	BUY	$2.15 - $6.21 $98,123 - $283,418	45,639 New	45,639 $110,000
Q1 2018 May 15, 2018	SELL	$20.0 - $23.28 $546,880 - $636,568	-27,344 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$17.93 - $30.3 $490,277 - $828,523	27,344	27,344 $607,000

Ticker ERYP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,018,600
Market Cap $16.8M
Description
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.